What Is GHK-Cu?
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding peptide that has been studied for its potential roles in tissue repair, skin quality, inflammation signaling, and regenerative processes. While it is widely known in topical skincare, GHK-Cu using subcutaneous (subQ) administration has effects on recovery, collagen signaling, and overall tissue health.
GHK-Cu is not a hormone and does not act like GLP-1 or growth-hormone–based therapies. Instead, it functions primarily as a biological signaling peptide.
How Does GHK-Cu Work?
GHK-Cu interacts with several cellular pathways involved in repair and regeneration:
- Copper-binding activity — Helps transport copper ions involved in enzymatic and healing processes.
- Collagen and tissue signaling — Studied for its role in supporting extracellular matrix activity and skin integrity.
- Anti-inflammatory pathways — May influence signals related to tissue recovery and oxidative stress.
- Cell communication — Acts as a messenger peptide that may help regulate gene expression linked to repair mechanisms.
Rather than stimulating appetite hormones or metabolism directly, GHK-Cu works through cellular signaling and regenerative pathways.
Potential Benefits?
- Support for skin quality and collagen signaling
- Research interest in tissue repair and recovery
- Possible support for hair and scalp health
- Anti-inflammatory and antioxidant signaling in some studies
Side Effects and Safety Considerations?
- Injection-site irritation or redness
- Mild fatigue or headache in some individuals
- Skin sensitivity or flushing
Recommended Dosing Schedule?
Estimated half-life is relatively short (hours rather than days).
Why it matters:
- Does not remain in the body as long as weekly metabolic peptides
- Often studied using more frequent administration rather than weekly dosing
- Effects are linked to signaling pathways rather than long drug accumulation
Steady state refers to when levels entering and leaving the body balance out. With shorter-acting peptides like GHK-Cu, steady state — if applicable — is typically reached more quickly compared to long-acting weekly compounds.
Focus on consistent, moderate administration rather than large dose escalations. 2mg daily is a good starting point.
Increasing the amount is not always necessary. If you are achieving desired outcomes without significant negative side effects, maintaining a stable approach may be more appropriate than continually increasing.
Our pens have an adjustable dose of 2–5mg, and a shelf life of 12–18 months.